BNET Industries

Market Cap:$35.5M
Last Fiscal Year Sales:$266.7K
  • Public
  • CA
Dow Jones Description

One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. This year marks the 25th anniversary of Genzyme's founding. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 8,500 employees in locations spanning the globe and 2005 revenues of $2.7 billion. Genzyme has been selected by FORTUNE as one of the "100 Best Companies to Work for" in the United States. With many established products and services helping patients in more than 80 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopedics, cancer, transplant and immune diseases, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as heart disease and other areas of unmet medical need. Genzyme is a registered trademark of Genzyme Corporation or its subsidiaries. All rights reserved.

President
John P Butler
Number of Employees 142
Contact Information

20353 64th Avenue Suite 200

Langley, British Columbia V2Y 1N5

www.anormed.com

(604) 530-1057

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

News & Analysis

anormed inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
John P Butler President
Gary J. Bridger Vice President, R & D & Chief Scientific Officer
Elisabeth Whiting Vice President, Corp Development & Communications
Gary B. Calandra Vice President, Clinical Development
Renato T. Skerlj Vice President, Chemistry
Larry Rhoads Director of Information Technology
Todd Strand National Marketing Director
Alex Lauerman Programmer Analyst
Jerry Jurgensen
Paul A. Brennan Active Member
Colin R. Mallet Director
Felix J. Baker Director

Board of Directors

Name (plus bio) Position
David Scott Chairman
Alysia Carlson Board of Directors
Barbara Walker Board of Directors
Christopher Devolder Board of Directors
Edward J. Wawrzynczak Board of Directors
Eve E. Slater Board of Directors
Julia G. Levy Board of Directors
Michael E. Phillips Board of Directors
Michael J. Abrams Board of Directors
Michael J. Cleare Board of Directors
Willem Wassenaar Board of Directors

Organization Position Status
AnorMED, Inc. President Current

Organization Position Status
AnorMED, Inc. Vice President, R & D & Chief Scientific Officer Current
Johnson Matthey, Inc. Former
University of Manchester Institute of Science and Technology Ph.D. in Chemistry Former
Boston College did post-doctoral research Former

Organization Position Status
AnorMED, Inc. Vice President, Corp Development & Communications Current
University of Ottawa Masters of Science degree Former

Organization Position Status
AnorMED, Inc. Vice President, Clinical Development Current
Merck & Co. Inc. Former

Organization Position Status
AnorMED, Inc. Vice President, Chemistry Current

Organization Position Status
AnorMED, Inc. Director of Information Technology Current
Naval Postgraduate School Master Degree In Computer Science Former

Organization Position Status
AnorMED, Inc. National Marketing Director Current

Organization Position Status
AnorMED, Inc. Programmer Analyst Current

Jerry Jurgensen is chief executive officer of Nationwide, one of the largest diversified insurance and financial services companies in the world. He was elected to this position in July 2000. With an emphasis on financial discipline and an improved corporate culture, Jurgensen has led Nationwide to high levels of performance. During his tenure, Nationwide's net income has increased from $138 million in 2001 to $2 billion in 2006 and 2007. Jurgensen previously served as executive vice president of Bank One Corporation, where he headed corporate banking and commercial banking products. Prior to that, he was executive vice president of Norwest Corporation. He is a member of numerous business and civic organizations, including the boards of the Law Enforcement Foundation of Ohio, Ohio State University Hospital and Nationwide Children's Hospital. He also is a member of the Financial Services Roundtable, The Ohio Business Roundtable, The Business Roundtable, Columbus Downtown Development Corporation and The Columbus Partnership. He is co-chair of the Ohio Governor's Public-Private Collaborative Commission. Additionally, Jurgensen serves on the board of Achieve, Inc., and is a member of the Business Higher Education Forum. He also serves on the board of directors for ConAgra Foods, Inc. Jurgensen earned a bachelor's degree in finance and an MBA from Creighton University.

Organization Position Status
Nationwide Autowatch Chief Executive Officer Current
Nationwide Federal Credit Union Chief Executive Officer Current
AnorMED, Inc. Current
Columbus Downtown Development Corporation Board of Directors Current
The Financial Services Roundtable Board of Directors Current
Loyola University Board of Directors Current
Nationwide Mutual Insurance Company Chief Executive Officer Former
Achieve Inc. Board of Directors Current
Norwest Corporation Executive Vice President Former
Bank One Corp Executive Vice President Former
Creighton University MBA Former
Creighton University Bachelor's Degree In Finance Former

Mr. Brennan joined Aspreva from AnorMED Inc. where he recently held the title of Acting President & VP Business Development. Mr. Brennan also participated as an active member in AnorMED's Board of Directors, representing the management team and providing operational updates. Previously in his role as Vice President of Business Development at AnorMed, he was responsible for product strategy, marketing, corporate and strategic planning, business development, and licensing. This position also involved extensive external contact with potential collaborators in the US, EU and Japan and included most of the top 20 pharmaceutical and biotech companies. Prior to his tenure at AnorMED, Mr. Brennan held the positions of Director, Global Licensing at AstraZeneca plc in Alderley Park in the UK and Director, Business Development and Licensing at Astra Draco AB, a subsidiary within Astra AB. Mr. Brennan holds a M.Sc. in Physiology as well as a B.Sc (Hons) in Life Sciences from Queen's University in Kingston, Ontario.He lectures at the Simon Frazer University MBA Biotechnology Program.

Organization Position Status
Aspreva Pharmaceuticals Corporation Senior Vice President Business Development Current
AnorMED, Inc. Active Member Current
AnorMED, Inc. Acting President Former
AnorMED, Inc. President & Vice President Former
AstraZeneca PLC Former

Organization Position Status
AnorMED, Inc. Chairman Current
AnorMED, Inc. Board of Directors Current

Organization Position Status
AnorMED, Inc. Board of Directors Current
Kansas Wind Power Cfo Former
Wells Fargo Bank Vice President of Strategy and Finance Former
Andersen Corporation Former
University of California Santa Cruz BA In Economics Former

Ms. Walker has a degree in Communication Design from Johnson County Community College and 14 years experience in that field. Her additional 15+ years of experience in multiple industries (including non-profit, government, insurance, engineering, accounting, wholesale and manufacturing) gives her an ideal understanding of the requirements of business. Ms. Walker is the Owner/Designer of Intuitive Design. She is a member of several environmental organizations and has a personal goal to advance sustainable design practices in existing and new construction for the average home owner.

Organization Position Status
Intuitive Design Corporation Owner Current
AnorMED, Inc. Board of Directors Current

M Christopher DeVolder is the Director of Sustainability and an Architect and Associate for CDFM2 Architecture. Mr. DeVolder has over 10 years experience in sustainable design on the commercial and residential markets. His desire to provide a better world for his children has fueled his passion for sustainable design and renewable energy. As a LEED (Leadership in Energy and Environmental Design) Accredited Professional, Mr. DeVolder has provided leadership in the sustainable design field to a diversity of clients and consultants. Mr. DeVolder serves as the Chairman of the American Institute of Architects Committee on the Environment for Kansas City. This group has put together a number of critically acclaimed seminars and programs in sustainable design the past two years. With his involvement in the Prairie Village Environmental Committee, the annual Earth Fair of Prairie Village has grown in attendance by 50% a year the last two years. He has lectured on sustainable design throughout the country and participated in the Buildings for a Livable Future workshop and the Green By Design conference. Mr. DeVolder is a member of the prestigious Centurions Leadership Program through the Kansas City Chamber of Commerce, a 2 year program to develop the region s top young leaders recognized for their civic and professional accomplishments. Mr. DeVolder is the founder of zero3, a Kansas City company specializing in sustainable design and renewable energy.

Organization Position Status
The Architecture Company Director of Sustainability Current
The Architecture Company Architect Current
AnorMED, Inc. Board of Directors Current

Organization Position Status
Haynes Capital Corp Current
Scandipharm, Inc. Chairman, Corporate Governance and Nominating Committee, Member, Compensation Committee Current
AnorMED, Inc. Director Current
Axcan Pharma, Inc. Board of Directors Current
Urso Fortetm Board of Directors Current
Corporate Governance Board of Directors Current
Ultrase Board of Directors Current
Methylgene Inc Director Current
Isotechnika Inc. Director Current
Migenix, Inc. Director Current
Novartis AG Officer Former
Canadian Association Chair Former
Urso Fortetm Chairman, Corporate Governance and Nominating Committee, Member, Compensation Committee Former
Cambridge University B.A. Degree Former
Corporate Governance Member Former

Organization Position Status
AnorMED, Inc. Board of Directors Current

Organization Position Status
Theravance, Inc. Board of Directors Current
Vertex Pharmaceuticals Incorporated Board of Directors Current
Phase Forward Incorporated Board of Directors Current
AnorMED, Inc. Board of Directors Current
Merck & Co. Inc. chief safety officer Former
Merck & Co. Inc. Vice President, and later Senior Vice President of Clinical and Regulatory Development Former
Merck & Co. Inc. Executive Director of Biochemistry and Molecular Biology Former
Merck & Co. Inc. Senior Director Former
VaxGen, Inc. Board of Directors Former
Vassar College A.B. Degree Former

Dr. Felix J. Baker has served as a director of Neurogen Corporation since May 1999. Dr. Baker is a Managing Member of Baker Bros. Advisors, LLC, which he and his brother, Julian Baker, founded in 2000. Dr. Baker's firm manages Baker Brothers Investments, a family of long-term investment funds for major university endowments and foundations, which are focused on publicly traded life sciences companies. Dr. Baker's career as a fund-manager began in 1994 when he co-founded a biotechnology investing partnership with the Tisch Family. Dr. Baker holds a B.S. and a Ph.D. in Immunology from Stanford University, where he also completed two years of medical school. He is also a director of Conjuchem Inc., Seattle Genetics, Inc., and Trimeris, Inc.

Organization Position Status
Neurogen Corporation Managing Partner, Baker Brothers Investments Current
Conjuchem Inc Director, Managing Partner, Baker Brothers Investments Current
Seattle Genetics, Inc. Chairman Current
Synageva Biopharma Corp. Chairman of The Board Current
Seattle Genetics, Inc. Director Current
Presidio Pharmaceuticals, Inc. Board of Directors Current
Conjuchem Inc Board of Directors Current
AnorMED, Inc. Director Current
Trimeris, Inc. Board of Directors Current
Baker Bros Managing Member Current
Neurogen Corporation Director Current
Trimeris, Inc. Director Former
Stanford University Doctorate In Immunology Former
Stanford University Bachelor's Degree In Biology Former

Organization Position Status
QLT, Inc. Chief Scientific Officer Current
QLT, Inc. Vice President Current
AnorMED, Inc. Board of Directors Current
QLT, Inc. Board of Directors Current
QLT, Inc. Chief Executive Officer Former
QLT, Inc. President Former
QLT, Inc. co-founder Former
QLT, Inc. Executive Chairman Former

Organization Position Status
AnorMED, Inc. Board of Directors Current

Organization Position Status
BC Business Magazine Current
Inex Pharmaceuticals Corporation Director Current
Protiva Biotherapeutics Board of Directors Current
Migenix, Inc. Director Current
AnorMED, Inc. Board of Directors Current
AnorMED, Inc. CEO Former
AnorMED, Inc. President Former
AnorMED, Inc. Co-Founder Former
University of British Columbia Adjunct Professor Former
Johnson Matthey, Inc. Former
Massachusetts Institute Ph.D. In Chemistry Former
Massachusetts Institute of Technology Ph.D. in chemistry Former
Bowdoin College BA In Chemistry Former

Organization Position Status
AnorMED, Inc. Board of Directors Current

Organization Position Status
AnorMED, Inc. Board of Directors Current
Spectral Diagnostics Inc. Board of Directors Former
York University Master of Business Administration Former
University of Toronto Master of Science degree Former
The University of Western Ontario M.D Former
advertisement
AOM $28.42 +0.11 (0.39% )
Volume 3,295
Shares Outstanding 1.2M
Market Cap 35.5M
Year High 37.20
Year Low 21.81
Earnings Per Share 0.00
P/E Ratio N/A
Dividend 0.5454
Yield 1.9191
advertisement
Click Here